Recent Finacing
Recent Raise
Glyscend develops orally delivered polymer therapies that act in the gastrointestinal tract to treat type 2 diabetes, using a Johns Hopkins–originated polymer platform with R&D in Lowell, MA.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Glyscend Therapeutics.
